8-K: Semler Scientific Upsizes Convertible Notes Offering to $85 Million

Semler Scientific has successfully priced an upsized private offering of $85 million in convertible senior notes due 2030, with an option for initial purchasers to buy an additional $15 million.

Summary

• Semler Scientific announced a private offering of convertible senior notes due in 2030.
• The initial offering was for $75 million, but it was upsized to $85 million.
• The notes have a 4.25% interest rate, payable semi-annually.
• The initial conversion price is approximately $76.44 per share, a 25% premium over the stock price on January 23, 2025.
• The company also granted an option to initial purchasers to buy an additional $15 million in notes.
• Semler Scientific entered into capped call transactions to offset potential dilution from the note conversions.
• The company intends to use the net proceeds for general corporate purposes, including the acquisition of bitcoin.
• The net proceeds from the offering are estimated to be approximately $81.4 million, or $95.8 million if the option is fully exercised.
• The capped call transactions have an initial cap price of approximately $107.01 per share, a 75% premium over the stock price on January 23, 2025.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the successful upsized offering and the use of capped calls to mitigate dilution. However, the investment in bitcoin and the potential for dilution introduce some uncertainty.

Positives

• The offering was upsized from $75 million to $85 million, indicating strong investor interest.
• The company secured a 4.25% interest rate on the convertible notes.
• Capped call transactions are in place to reduce potential dilution from note conversions.
• The company has flexibility in how it uses the proceeds, including bitcoin acquisition.

Negatives

• The offering is a private placement, which may limit access for some investors.
• The notes are convertible, which could lead to dilution of existing shares if converted.
• The company is using a portion of the proceeds to acquire bitcoin, which is a volatile asset.

Risks

• The offering is subject to market conditions and may not close on the expected terms or at all.
• The conversion of the notes could dilute existing shareholders.
• The capped call transactions may not fully offset the dilution from note conversions.
• The price of Semler Scientific's common stock could be affected by the hedging activities of the option counterparties.
• The company's investment in bitcoin is subject to market volatility.

Future Outlook

The company intends to use the net proceeds for general corporate purposes, including the acquisition of bitcoin, and the capped call transactions are expected to offset potential dilution from the note conversions. The company may redeem the notes after August 4, 2028, under certain conditions.

Management Comments

• Semler Scientific intends to offer, subject to market conditions and other factors, $75.0 million aggregate principal amount of convertible senior notes due 2030.
• Semler Scientific also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $15.0 million principal amount of notes.
• Semler Scientific intends to use a portion of the net proceeds from the offering to pay the cost of the capped call transactions described below and the remainder of the net proceeds for general corporate purposes, including the acquisition of bitcoin.

Industry Context

This offering is a common method for companies to raise capital, especially for growth or strategic initiatives. The use of convertible notes allows for potential future equity conversion, which can be attractive to investors. The inclusion of capped call transactions is a standard practice to mitigate dilution.

Comparison to Industry Standards

• The 4.25% interest rate on the convertible notes is within the typical range for similar offerings by companies with a similar risk profile.
• The 25% conversion premium is also a common feature in convertible note offerings, designed to provide a balance between debt and potential equity conversion.
• The use of capped call transactions is a standard practice to reduce the potential dilutive effect of convertible notes, similar to what other companies in the technology and healthcare sectors do.
• The decision to allocate a portion of the proceeds to bitcoin is less common and reflects Semler Scientific's unique treasury strategy, which is not a standard practice among its peers.

Stakeholder Impact

• Shareholders may experience potential dilution if the notes are converted to equity.
• Creditors will have a new debt obligation to consider.
• The company's investment in bitcoin could impact its financial stability and performance.

Next Steps

• The sale of the notes is expected to close on January 28, 2025.
• The company will use the net proceeds for general corporate purposes and bitcoin acquisition.
• The company will make semi-annual interest payments on the notes starting August 1, 2025.
• The company may redeem the notes after August 4, 2028, under certain conditions.

Key Dates

Keywords

Convertible Notes, Private Offering, Capped Call Transactions, Bitcoin, Debt Financing, Dilution, Senior Notes, Semler Scientific, SMLR